Literature DB >> 29472829

Prostate Cancer Academy 2017 Summaries.

Dmitry Volkin1.   

Abstract

Entities:  

Keywords:  Androgen; Focal therapy; MRI targeted biopsy; Magnetic; Positron emission tomography; Prostate biopsy; Prostate cancer; Prostate-specific antigen; Radiation therapy; Tissue biomarkers; deprivation therapy; resonance imaging

Year:  2017        PMID： 29472829      PMCID： PMC5811883          DOI： 10.3909/riu0783

Source DB:  PubMed          Journal:  Rev Urol        ISSN： 1523-6161


× No keyword cloud information.
  19 in total

1.  Impact of the Cell Cycle Progression Test on Physician and Patient Treatment Selection for Localized Prostate Cancer.

Authors:  Neal D Shore; Naveen Kella; Brian Moran; Judd Boczko; Fernando J Bianco; E David Crawford; Thaylon Davis; Kirstin M Roundy; Kristen Rushton; Charles Grier; Rajesh Kaldate; Michael K Brawer; Mark L Gonzalgo
Journal:  J Urol       Date:  2015-09-25       Impact factor: 7.450

2.  Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapy.

Authors:  Robert B Den; Kasra Yousefi; Edouard J Trabulsi; Firas Abdollah; Voleak Choeurng; Felix Y Feng; Adam P Dicker; Costas D Lallas; Leonard G Gomella; Elai Davicioni; R Jeffrey Karnes
Journal:  J Clin Oncol       Date:  2015-02-09       Impact factor: 44.544

3.  Role of radical prostatectomy in metastatic prostate cancer: data from the Munich Cancer Registry.

Authors:  Christian Gratzke; Jutta Engel; Christian G Stief
Journal:  Eur Urol       Date:  2014-05-10       Impact factor: 20.096

4.  AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer.

Authors:  Emmanuel S Antonarakis; Changxue Lu; Hao Wang; Brandon Luber; Mary Nakazawa; Jeffrey C Roeser; Yan Chen; Tabrez A Mohammad; Yidong Chen; Helen L Fedor; Tamara L Lotan; Qizhi Zheng; Angelo M De Marzo; John T Isaacs; William B Isaacs; Rosa Nadal; Channing J Paller; Samuel R Denmeade; Michael A Carducci; Mario A Eisenberger; Jun Luo
Journal:  N Engl J Med       Date:  2014-09-03       Impact factor: 91.245

5.  Increased survival with enzalutamide in prostate cancer after chemotherapy.

Authors:  Howard I Scher; Karim Fizazi; Fred Saad; Mary-Ellen Taplin; Cora N Sternberg; Kurt Miller; Ronald de Wit; Peter Mulders; Kim N Chi; Neal D Shore; Andrew J Armstrong; Thomas W Flaig; Aude Fléchon; Paul Mainwaring; Mark Fleming; John D Hainsworth; Mohammad Hirmand; Bryan Selby; Lynn Seely; Johann S de Bono
Journal:  N Engl J Med       Date:  2012-08-15       Impact factor: 91.245

6.  Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion-targeted Prostate Biopsy Outcomes.

Authors:  Xiaosong Meng; Andrew B Rosenkrantz; Neil Mendhiratta; Michael Fenstermaker; Richard Huang; James S Wysock; Marc A Bjurlin; Susan Marshall; Fang-Ming Deng; Ming Zhou; Jonathan Melamed; William C Huang; Herbert Lepor; Samir S Taneja
Journal:  Eur Urol       Date:  2015-06-22       Impact factor: 20.096

7.  A phase III extension trial with a 1-arm crossover from leuprolide to degarelix: comparison of gonadotropin-releasing hormone agonist and antagonist effect on prostate cancer.

Authors:  E David Crawford; Bertrand Tombal; Kurt Miller; Laurent Boccon-Gibod; Fritz Schröder; Neal Shore; Judd W Moul; Jens-Kristian Jensen; Tine Kold Olesen; Bo-Eric Persson
Journal:  J Urol       Date:  2011-07-23       Impact factor: 7.450

8.  Cardiovascular morbidity associated with gonadotropin releasing hormone agonists and an antagonist.

Authors:  Peter C Albertsen; Laurence Klotz; Bertrand Tombal; James Grady; Tine K Olesen; Jan Nilsson
Journal:  Eur Urol       Date:  2013-11-01       Impact factor: 20.096

Review 9.  Dose-Escalated Robotic SBRT for Stage I-II Prostate Cancer.

Authors:  Robert Meier
Journal:  Front Oncol       Date:  2015-04-07       Impact factor: 6.244

10.  A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling.

Authors:  Eric A Klein; Matthew R Cooperberg; Cristina Magi-Galluzzi; Jeffry P Simko; Sara M Falzarano; Tara Maddala; June M Chan; Jianbo Li; Janet E Cowan; Athanasios C Tsiatis; Diana B Cherbavaz; Robert J Pelham; Imelda Tenggara-Hunter; Frederick L Baehner; Dejan Knezevic; Phillip G Febbo; Steven Shak; Michael W Kattan; Mark Lee; Peter R Carroll
Journal:  Eur Urol       Date:  2014-05-16       Impact factor: 20.096
View more
  1 in total

1.  Preserving Independent Urology: LUGPA's First Decade.

Authors:  Neal D Shore; Deepak A Kapoor; Evan R Goldfischer; David C Chaikin; Earl L Walz; R Jonathan Henderson; Richard G Harris; Robert D Asinof; Gary M Kirsh
Journal:  Rev Urol       Date:  2019
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.